Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
Completed · Phase 3
Conditions studied: Glabellar Lines, Lateral Canthal Lines
In brief
This is a phase 3, multicenter, open-label study to evaluate the safety of QM1114-DP for the long term treatment of moderate to severe Glabellar (Frown) Lines (GL) and Lateral Canthal Lines (Crow's Feet and LCL).
Key facts
- Study ID
- NCT04225260
- Run by
- Galderma R&D
- People needed
- 902
- Starts
- 2020-01-27
- Expected to finish
- 2021-05-21
- Last updated by the study team
- 2023-06-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female at least 18 years of age.
You may not qualify if…
- Previous use of any Botulinum toxin in facial areas within 9 months prior to study treatment.
- Anticipated need for treatment with botulinum toxin of any serotype for any reason during the study (other than the investigational product).
- Female who is pregnant, breast feeding, or intends to conceive a child during the study.
- Known allergy or hypersensitivity to any component of the investigational product (QM1114-DP) or any botulinum toxin serotype.
Where it is running
- Total Skin and Beauty Dermatology Center, PC — Birmingham, Alabama, United States
- Investigate MD, LLC. — Scottsdale, Arizona, United States
- Center for Dermatology Clinical Research, Inc. — Fremont, California, United States
- Rejuva Medical Aesthetics, LLC — Los Angeles, California, United States
- Westside Aesthetics — Los Angeles, California, United States
- Marcus Facial Plastic Surgery — Redondo Beach, California, United States
- The Maas Clinic Research Center — San Francisco, California, United States
- ArteMedica — Santa Rosa, California, United States
- AboutSkin Research, LLC — Greenwood Village, Colorado, United States
- Modern Dermatology PC — Westport, Connecticut, United States
- Center for Clinical and Cosmetic Research — Aventura, Florida, United States
- Steven Fagien, MD, PA — Boca Raton, Florida, United States
- Susan H. Weinkle, M.D — Bradenton, Florida, United States
- Miami Skin and Vein LLC — Coral Gables, Florida, United States
- Mayoral Dermatology — Coral Gables, Florida, United States
- Skin Research Institute, LLC — Coral Gables, Florida, United States
- Research Institute of SouthEast, LLC — West Palm Beach, Florida, United States
- Hamilton Research LLC — Alpharetta, Georgia, United States
- Chicago Cosmetic Surgery and Dermatology, Inc — Chicago, Illinois, United States
- Pure Dermatology, LLC — Metairie, Louisiana, United States
- SkinCare Physicians — Chestnut Hill, Massachusetts, United States
- Skin Laser and Surgery Specialist of NY/NJ — Hackensack, New Jersey, United States
- Elite Aesthetic Research — Cincinnati, Ohio, United States
- Aventiv Research, Inc. — Dublin, Ohio, United States
- Dallas Plastic Surgery Institute — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.